Hepatic fibrosis occurs when scar tissue replaces damaged cells in the liver. Over time, accumulating scarring distorts the liver, interferes with its blood supply and may progressively lead to worsening consequences, from ...
Sep 27, 2023
0
0
A research group from the Graduate School of Medicine and Research Institute of Environmental Medicine at Nagoya University report that cholesterol accumulation in macrophages promotes liver fibrosis in the development of ...
Sep 19, 2023
0
4
Chronic liver injury results in the development of liver fibrosis in approximately 25% of individuals in response to diverse insults, and several aspects of the development of liver injury appear to be common to a variety ...
Aug 31, 2023
0
0
A pair of stem cell cloning experts at the University of Houston is reporting their findings of variant cells in the lungs of patients with idiopathic pulmonary fibrosis (IPF) which likely represent key targets in any future ...
May 17, 2023
0
45
Abnormal sleep patterns, like those of night-shift workers, disrupt the body's natural biological clock and have been linked to lung health issues. A new study by University of Rochester Medical Center (URMC) researchers ...
Apr 17, 2023
0
44
Yale researchers have identified a possible driver of the persistent inflammation that causes irreversible lung damage in patients with cystic fibrosis, a genetic disorder that impairs breathing and digestion.
Dec 13, 2022
0
102
An international team of researchers has revealed how scarring occurs in long COVID and pulmonary fibrosis using innovative blood biomarkers and X-ray technology. This study, published in eBioMedicine, contributes to the ...
Nov 2, 2022
0
5
Idiopathic pulmonary fibrosis could become the first degenerative disease to be treated through the science of aging.
Oct 6, 2022
0
54
Chronic diseases often lead to fibrosis, a condition in which organ tissue suffers from excessive scarring. Researchers at the University of Zurich have now developed an immunotherapy that specifically targets the cause—activated ...
Sep 15, 2022
0
36
An experimental cancer drug with a favorable safety profile shows promise as a treatment for Idiopathic Pulmonary Fibrosis (IPF), according to a study published on August 23, 2022, in the American Journal of Respiratory and ...
Sep 1, 2022
0
301
